Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RXRX | RECURSION PHARMACEUTICALS, INC. | Director | $15.6M | Oct 1, 2025 | ||
MRK | Merck & Co., Inc. | Executive VP & President, MRL | $6.57M | Apr 29, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|